Ukwelashwa kwe-Proton kwentombazane eneminyaka eyishumi ene-astrocytoma

Yabelana ngalokhu okuthunyelwe

Ukwelashwa kwe-Proton ku-astrocytma kwazanywa okokuqala ngqa ngo-2012.

Ngo-2012, u-Annabelle watholakala ene-fibroblastic astrocytoma, isimila ebuchosheni. Ukuhlinzwa kususe iningi lesimila kodwa ngeshwa isimila saphinde sabuya ngo-2014.

Uthole ukwelashwa kwe-proton beam ngo-2015 e-Annabelle Higgins, e-Oklahoma.
Ukuhlinzwa kwenziwa futhi ngo-2015. Kodwa-ke, ezinye izimila zase zikhule zafinyelela esiqwini sobuchopho, ngakho u-Annabelle waphakanyiswa ukuthi aye e-University of California Los Angeles (UCLH) ethimbeni le-radiation therapy i-proton ukwelashwa. Ukukhethwa kokwelashwa kwe-proton beam kuyaxoxwa ngakho, futhi kuthathwa njengokwelashwa okungcono kakhulu ngoba ukwelashwa kwe-proton beam kunganciphisa imiphumela emibi yesikhathi eside ebangelwa i-radiotherapy.

 

Ngemva kwezinyanga ezimbalwa, amalungiselelo okulungiselela e-Annabelle's Oklahoma Proton Therapy aqedwa njengengxenye yohlelo lweNational Health Service's (NHS) phesheya kwezilwandle. Ekupheleni kukaJuni 2015, u-Annabelle nabazali bakhe bandizela e-Oklahoma futhi baqala ukwelashwa kwe-proton ngemuva kwekhefu elifushane. Ngesikhathi sokwelashwa kuka-Annabelle, umndeni wakhe wazizwa ulalele kakhulu.

Uyise, uStephen, uthe: “U-Annabelle akazange abe nemiphumela emibi edalwe ukwelashwa kwe-proton. Uvele waqothuka ezinye izinwele wabukeka ekhathele kakhulu kunokwejwayelekile.”

Phakathi nokwelashwa, izinhlangano zendawo zahlela imicimbi ekhethekile ka-Annabelle nomndeni wakhe. Le micimbi isebenzisa ngokugcwele ikhono lika-Annabelle lokushushuluza, umculo nokudansa. UStephen wachaza: “Saya endaweni ye-ice rink yendawo futhi umqeqeshi wamyala ukuba ashibilike, base bethola ukuthi usuku lokuzalwa luka-Annabelle lwalusondela base bemenzela iphathi yosuku lwakhe lokuzalwa kusenesikhathi.”

Ngemva kwalokho, umndeni wakwa-Annabelle wabamba iqhaza emqhudelwaneni waminyaka yonke wokushushuluza owawubanjelwe kule ndawo yeqhwa; U-Annabelle uvele kukhava yalolu hlu, wacula iculo lesizwe laseMelika, futhi konke ukusebenza kwaqoshwa futhi kwaqoshwa! Umndeni wakwa-Annabelle kanye nomqeqeshi wakhe baphinde bavakashela amanyuvesi endawo futhi bavakashela izinhlangano ezisiza abantu abanomdlavuza. UStephen uthe, “Lapho u-Annabelle ejabule khona kakhulu, lokhu kuyinto enhle kakhulu.”

Yize umndeni ube nesikhathi esimnandi, uStephen uthe kwenza abantu “bakhathazeke futhi bakhathazeke” ngokuza lapha, futhi wacabanga ukuthi kungaba lula uma iLondon ingalolu hlobo lokwelashwa kwe-proton beam. “Abanye abantu e-Oklahoma, sikude nabangane nomndeni. Uma i-proton beam therapy ingahlala eLondon, asikho isidingo sokundiza kuze kube manje, akukho jet lag futhi umndeni nabangane baseduze. "

U-Annabelle walulama kakhulu ngemva kokwelashwa. Wabuyela esikoleni, wabuyela e-ice rink, futhi wahlanganyela embukisweni ngoKhisimusi. U-Annabelle uphinde abe yilungu leqembu lesikole le-basketball le-paddleless, futhi ujabulela impilo eyanelisayo nsuku zonke.

 

Shayela ku- +91 96 1588 1588 ukuze uthole ukubonisana nokwelashwa kwe-proton noma ubhalele ku-cancerfax@gmail.com.

Bhalisa ku-Newsletter yethu

Thola izibuyekezo futhi ungalokothi uphuthelwe ibhulogi evela kuCancerfax

Okuningi Okuzohlolwa

I-Lutetium Lu 177 dotatate igunyazwe yi-USFDA yeziguli zezingane ezineminyaka engu-12 nangaphezulu nge-GEP-NETS
Cancer

I-Lutetium Lu 177 dotatate igunyazwe yi-USFDA yeziguli zezingane ezineminyaka engu-12 nangaphezulu nge-GEP-NETS

I-Lutetium Lu 177 dotatate, ukwelashwa okuyisimangaliso, isanda kuthola imvume evela kwa-US Food and Drug Administration (FDA) yeziguli zezingane, okumaka ingqopha-mlando ku-oncology yezingane. Lokhu kugunyazwa kumelele ukukhanya kwethemba ezinganeni ezilwa nezimila ze-neuroendocrine (NETs), uhlobo lomdlavuza oluyivelakancane kodwa oluyinselele oluvame ukufakazela ukumelana nemithi evamile.

I-Nogapendekin alfa inbakicept-pmln igunyazwe yi-USFDA yomdlavuza wesinye ongasabeli we-BCG ongaphenduli.
Umdlavuza wesibeletho

I-Nogapendekin alfa inbakicept-pmln igunyazwe yi-USFDA yomdlavuza wesinye ongasabeli we-BCG ongaphenduli.

“I-Nogapendekin Alfa Inbakicept-PMLN, i-immunotherapy enoveli, ibonisa isithembiso ekwelapheni umdlavuza wesinye uma kuhlanganiswa nokwelashwa kwe-BCG. Le ndlela yokusungula iqondise izimpawu ezithile zomdlavuza ngenkathi isebenzisa impendulo yamasosha omzimba, ithuthukisa ukusebenza kahle kwemithi yokwelapha yendabuko efana ne-BCG. Izivivinyo zemitholampilo zembula imiphumela ekhuthazayo, ekhombisa imiphumela ethuthukisiwe yesiguli kanye nentuthuko engaba khona ekulawuleni umdlavuza wesinye. Ukusebenzisana phakathi kwe-Nogapendekin Alfa Inbakicept-PMLN kanye ne-BCG kumemezela inkathi entsha yokwelashwa komdlavuza wesinye.”

Dinga usizo? Ithimba lethu likulungele ukukusiza.

Sifisela ukululama okusheshayo kothandekayo wakho futhi oseduze.

Qala ingxoxo
Siku-inthanethi! Xoxa Nathi!
Skena ikhodi
Sawubona,

Siyakwamukela kuCancerFax!

ICancerFax iyinkundla yokuphayona ezinikele ekuxhumaniseni abantu ababhekene nomdlavuza oseqophelweni eliphezulu ngemithi yokwelapha yamangqamuzana efana ne-CAR T-Cell therapy, ukwelashwa kwe-TIL, nezivivinyo zomtholampilo emhlabeni wonke.

Sazise ukuthi yini esingakwenzela yona.

1) Ukwelashwa komdlavuza phesheya?
2) Ukwelashwa kwe-CAR T-Cell
3) Umuthi wokugomela umdlavuza
4) Ukubonisana ngevidiyo eku-inthanethi
5) Ukwelashwa kweProton